ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

NIBAN2/FLII/RREB1 Axis Drives Glioma Stem Cell Malignancy via TLR3 Pathway Activation.

Liang Liang Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.